Maryland 2026 Session Status: Introduced 8 D cosponsors

HB1477 — Public Health - Ibogaine Clinical Research Grant Program - Establishment (Veterans Mental Health Innovations Act)

Last action — Hearing (Primary, House of Origin)

  1. 1
    Introduced
  2. 2
    In Committee
  3. 3
    Passed House of Delegates
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill has been introduced in the House of Delegates. Introduced February 13, 2026. It must pass committee before a floor vote.

Next likely step: a committee referral and hearing.

Odds of enactment

Low chance

Based on the sponsor, cosponsors, and committee posture, this bill has a low chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Not enough signal yet

Not enough signal yet to read this bill's trajectory — we surface a likelihood only once there's real movement (stage, sponsorship, committee, or votes) to point to.

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

Summary

Establishing the Ibogaine Clinical Research Grant Program to provide grants to certain research institutions to conduct certain clinical drug development trials on the use of ibogaine; and including the Program as an authorized use of funding from the Opioid Restitution Fund.

Bill Text

We don't have the full text on file for this bill yet.

Read HB1477 on the official Maryland source →

Action History

  1. Hearing (Primary, House of Origin)

  2. First Reading (House of Origin)

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 9 co-sponsors · 178 not signed on

Sponsors (1)

Co-sponsors (9)

Not signed on (178)

178 members have not signed on to this bill.

Show all 178 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

veterans healthcare
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HB1477 do?
Establishing the Ibogaine Clinical Research Grant Program to provide grants to certain research institutions to conduct certain clinical drug development trials on the use of ibogaine; and including the Program as an authorized use of funding from the Opioid Restitution Fund.
Who sponsors HB1477?
HB1477 is sponsored by Delegate Holmes, Delegate Darrell Odom (Democrat), Delegate Dylan Behler (Democrat), Delegate Adrian Boafo (Democrat), Delegate Diana M. Fennell (Democrat), Delegate Mary A. Lehman (Democrat), Long, J., Delegate N. Scott Phillips (Democrat), Delegate Mike Rogers (Democrat), and Delegate Gary Simmons (Democrat).
What is the current status of HB1477?
This bill has been introduced in the House of Delegates. Introduced February 13, 2026. It must pass committee before a floor vote.
Where can I track HB1477?
Track HB1477 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB1477

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HB1477

Last checked for changes about 23 hours ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →